ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,409,760 | -33.7% | 62,262 | -0.8% | 0.01% | -30.8% |
| Q2 2023 | $11,180,531 | +104147.4% | 62,745 | -3.5% | 0.01% | 0.0% |
| Q1 2023 | $10,725 | +4.1% | 65,015 | -0.7% | 0.01% | -7.1% |
| Q4 2022 | $10,307 | -99.9% | 65,448 | +7.4% | 0.01% | 0.0% |
| Q3 2022 | $9,178,000 | -5.5% | 60,941 | +3.1% | 0.01% | 0.0% |
| Q2 2022 | $9,717,000 | -17.9% | 59,112 | +11.2% | 0.01% | -6.7% |
| Q1 2022 | $11,834,000 | -8.5% | 53,155 | -2.5% | 0.02% | -6.2% |
| Q4 2021 | $12,937,000 | +4.0% | 54,507 | +2.2% | 0.02% | -5.9% |
| Q3 2021 | $12,443,000 | +10.4% | 53,315 | -2.6% | 0.02% | +13.3% |
| Q2 2021 | $11,271,000 | -1.2% | 54,766 | -1.3% | 0.02% | 0.0% |
| Q1 2021 | $11,403,000 | -5.2% | 55,505 | -1.0% | 0.02% | -11.8% |
| Q4 2020 | $12,023,000 | +17.7% | 56,053 | +0.3% | 0.02% | +6.2% |
| Q3 2020 | $10,216,000 | -3.1% | 55,899 | -2.3% | 0.02% | -11.1% |
| Q2 2020 | $10,548,000 | -6.0% | 57,230 | +2.9% | 0.02% | -25.0% |
| Q1 2020 | $11,221,000 | +13.6% | 55,614 | +5.4% | 0.02% | +41.2% |
| Q4 2019 | $9,877,000 | +16.0% | 52,782 | -1.0% | 0.02% | +6.2% |
| Q3 2019 | $8,511,000 | -31.8% | 53,330 | +7.6% | 0.02% | -30.4% |
| Q2 2019 | $12,484,000 | +13.6% | 49,559 | +8.0% | 0.02% | +9.5% |
| Q1 2019 | $10,985,000 | +5.5% | 45,901 | +1.3% | 0.02% | -8.7% |
| Q4 2018 | $10,408,000 | +11.3% | 45,326 | +37.1% | 0.02% | +27.8% |
| Q3 2018 | $9,349,000 | -3.2% | 33,065 | +0.5% | 0.02% | -5.3% |
| Q2 2018 | $9,661,000 | +22.6% | 32,901 | +5.4% | 0.02% | +18.8% |
| Q1 2018 | $7,877,000 | +0.8% | 31,209 | -13.7% | 0.02% | 0.0% |
| Q4 2017 | $7,812,000 | +35.0% | 36,168 | +16.2% | 0.02% | +23.1% |
| Q3 2017 | $5,786,000 | +9.8% | 31,131 | +1.9% | 0.01% | +8.3% |
| Q2 2017 | $5,271,000 | +12.1% | 30,556 | -0.8% | 0.01% | +9.1% |
| Q1 2017 | $4,703,000 | +45.0% | 30,799 | +39.9% | 0.01% | +37.5% |
| Q4 2016 | $3,243,000 | +21.8% | 22,009 | +4.4% | 0.01% | +14.3% |
| Q3 2016 | $2,663,000 | +18.4% | 21,073 | +5.6% | 0.01% | 0.0% |
| Q2 2016 | $2,250,000 | +2.9% | 19,954 | -5.0% | 0.01% | 0.0% |
| Q1 2016 | $2,187,000 | -1.0% | 21,009 | +7.3% | 0.01% | 0.0% |
| Q4 2015 | $2,209,000 | +7.9% | 19,584 | +4.8% | 0.01% | 0.0% |
| Q3 2015 | $2,047,000 | +20.8% | 18,692 | +5.5% | 0.01% | +40.0% |
| Q2 2015 | $1,695,000 | -13.0% | 17,715 | -15.3% | 0.01% | -16.7% |
| Q1 2015 | $1,948,000 | +14.8% | 20,915 | +1.0% | 0.01% | +20.0% |
| Q4 2014 | $1,697,000 | +34.3% | 20,715 | +5.2% | 0.01% | +25.0% |
| Q3 2014 | $1,264,000 | +1.9% | 19,690 | -3.5% | 0.00% | 0.0% |
| Q2 2014 | $1,241,000 | +29.3% | 20,410 | +27.3% | 0.00% | +33.3% |
| Q1 2014 | $960,000 | -9.9% | 16,030 | -4.1% | 0.00% | 0.0% |
| Q4 2013 | $1,065,000 | -8.1% | 16,715 | -2.1% | 0.00% | -25.0% |
| Q3 2013 | $1,159,000 | -5.7% | 17,065 | +0.0% | 0.00% | 0.0% |
| Q2 2013 | $1,229,000 | – | 17,059 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |